July 11, 2025

The July 2025 edition of the Alverno Laboratories Test Bulletin includes several important updates. The soft code for Mycoplasma hominis/Ureaplasma Culture has changed from URMHC to MHURC, effective June 30, 2025, with no changes to specimen type, source, or transport requirements. Several Quest Diagnostics tests have been discontinued, including HLA-B 1502, Narcolepsy HLA-QDB1, and Oxalate Serum/Plasma tests; replacements must now be ordered as UNCMS and include updated specimen collection guidelines. T3 Uptake testing will now be permanently referred to Quest Diagnostics due to the manufacturer discontinuing the reagent. While the performing lab has changed, the Soft code, specimen type, and transport temperature remain the same. Finally, Alverno Laboratories is transitioning HPV PCR testing to the Abbott Alinity m platform effective July 21, 2025. This new qualitative assay will differentiate HPV16, HPV18, and HPV45, and group additional high-risk genotypes into “Other A” and “Other B.” Specimen collection and transport procedures are unchanged.